High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Natsuo Tomita(Aichi Cancer Center), Takeshi Kodaira(Aichi Cancer Center), M. Yoshida(National Institutes for Quantum Science and Technology), Takumi Kageyama(Aichi Cancer Center), Yuji Ogura(Boehringer Ingelheim (Japan)), Norihito Soga(Aichi Cancer Center), Yutaro Koide(Aichi Cancer Center), Makoto Ito(Fujita Health University), Hiroyuki Tachibana(Aichi Cancer Center), Norio Hayashi(The University of Osaka), Kana Kimura(Aichi Cancer Center), Chiyoko Makita(Aichi Cancer Center)
Cited by 11
Related Papers
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses
|Gastroenterology|2004|220
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
|Hepatology Research|2005|192